REG - Biofrontera AG - Change of Trading Currency <Origin Href="QuoteRef">B8FGn.DE</Origin>
RNS Number : 0839PBiofrontera AG14 August 2014Biofrontera AG
("Biofrontera" or the "Company")
Change of Trading Currency
Biofrontera AG (AIM:B8F), the European biopharmaceutical company, announces that at 8:00 am today the trading currency of the Company will change from Euros to pence sterling.
For further information, please contact:
Biofrontera AG
Prof. Hermann Lbbert, Chief Executive Officer
Thomas Schaffer , Chief Financial Officer
Tel:+ 49 (0) 214 - 87632 - 22
finnCap (Nomad and Broker)
Geoff Nash / Christopher Raggett (Corporate Finance)
Tel: 020 7220 0500
Steven Norcross(Corporate Broking)
Investor Relations
Seton Services
Toni Vallen
Tel: 020 7603 6797
Financial PR
Gable Communications
Justine James/John Bick
Tel: 020 7193 7463
This information is provided by RNSThe company news service from the London Stock ExchangeENDMSCPJMFTMBJBBPI
Recent news on Biofrontera AG
See all newsRCS - Maruho Deutschland - Extraordinary General Meeting on 7 April 2022
AnnouncementREG - AIM Biofrontera AG - Cancellation - Biofrontera AG <Origin Href="QuoteRef">B8FGn.DE</Origin>
AnnouncementREG - Biofrontera AG - Private Placement <Origin Href="QuoteRef">B8FGn.DE</Origin>
AnnouncementREG - Biofrontera AG - Phase III studies update <Origin Href="QuoteRef">B8FGn.DE</Origin>
AnnouncementREG - Biofrontera AG - Excellent results in Ameluz BCC clinical study <Origin Href="QuoteRef">B8FGn.DE</Origin>
Announcement